BioCentury

7:00 AM GMT, Oct 26, 2009
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Status

Taspoglutide: Completed Phase III enrollment

Roche completed enrollment of 990 patients with Type II diabetes mellitus inadequately controlled with metformin plus sulphonylurea in the open-label,

Read the full 208 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.